News

doctor notes
AI course-of-care notes help doctors, pose little risk of harm to patients

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Subhasis Chatterjee, MD. FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Texas Heart Institute at CHI Baylor St. Lukes, explains the new 2026 expert consensus on heparin induced thrombocytopenia (HIT) released at the American Association for Thoracic Surgery (AATS) 2026 annual meeting. #AATS #AATS2026 #AATS26
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

doctor wrong patient wrong-site surgery medical error malpractice mistake
FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

How expert guidelines have influenced TAVR vs. SAVR decisions

As popular as TAVR is today, SAVR continues to play a significant role in the management of patients with valvular disease. 

Nicole B. Saphier, MD
Opposition forming against radiologist nominee for surgeon general

“Dr. Saphier would be a catastrophic mistake on messaging and communicating with MAHA at a time where the coalition is very fragile,” one opponent says. 

Siemens Healthineers
Siemens Healthineers shakes up leadership team, cuts profit outlook

The Erlangen, Germany-based device manufacturer announced its quarterly earnings results on May 7, which included a 6.5% year-over-year decline in revenue for its diagnostics segment. 

Thumbnail
PSMA PET imaging’s proliferation produces uptick in aggressive treatment for prostate cancer

First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer. 

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.
CMS unveils $50 GLP-1 prescriptions for Medicare patients

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027. For $50 a month, Medicare beneficiaries will be able to access popular weight loss drugs, in hopes they will improve overall health.

Exo Iris AI inks another FDA clearance for pleural effusion
First AI-enabled POCUS app for detecting pleural effusion and atelectasis earns FDA clearance

The apps are embedded into the Exo Iris transducer, which can be plugged directly into a smartphone, utilized anywhere and without the internet. 

AMA president Bruce Scott, MD, warns prior authorization is hurting patients and causing doctors to call it quits.
AMA president warns prior authorization hurting patients, driving burnout and practice closures

American Medical Association President Bruce Scott, MD, explains the growing issues with insurance prior authorization impacting patient care and what the AMA is doing about it.

cannabis use disorder marijuana joint weed smoking
Cannabis is bad for the heart—should the risk be taken more seriously?

Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and highlighted the importance of discussing these risks with patients.

Thumbnail
Symptom-detected breast cancers more likely to require mastectomy, chemotherapy

New research adds to the “strong evidence” supporting screening guidelines and highlights the importance of women adhering to clinical recommendations. 

Around the web

Health Exec
AI course-of-care notes help doctors, pose little risk of harm to patients

Agentic large-language models can draft hospital discharge summaries that are safe, useful and demonstrably effective at helping to curb physician burnout, according to research conducted at Stanford University.

Cardiovascular Business
AATS helps heart surgeons diagnose and manage heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia after heart surgery is a major concern, but prior guidelines were developed without much feedback from actual cardiac surgeons.

Cardiovascular Business
FDA announces more recalls due to risk of syringe breaking during treatment

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

Design by Adaptive Theme